Lower levels of IFN -γ and IFN-γ-induced genes like CXCL9 contribute to decreased infiltration of CD8+ T cells and are correlated with tumor progression following anti-PD-L1 therapy [82]. The gene discussed is CD8A; the disease is neoplasm.